Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.

Revenue
+4.29%
EPS
+2.17%
Free cash flow
+27.0%
Total debt
−18.1%

Quarter to September 2026, against a year earlier

150.97 8.46 −5.31%
Market cap
$16.8B
P/E
71.9×
Fwd P/E
66.2×
Dividend yield
0.19%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100

Revvity Inc. (RVTY) Free cash flow

Alert me on Free cash flow

Revvity Inc.'s free cash flow for fiscal 2025 was $509.4M, down 5.95% from $541.7M in fiscal 2024. Over the twelve months to 30 September 2026 it was $602.5M. Over the past ten years it has ranged from $9.9M (fiscal 2023) to $1.3B (fiscal 2021); the current reading is higher than 64% of that period. Revvity Inc. ranks 12th of 49 Diagnostics & Research companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $509.4M (5.95%)
FY2024 $541.7M 5,369.01%
FY2023 $9.9M (98.33%)
FY2022 $594.2M (55.15%)
FY2021 $1.3B 59.07%
FY2020 $832.8M 194.61%
FY2019 $282.7M 10.51%
FY2018 $255.8M 2.14%
FY2017 $250.5M (26.32%)
FY2016 $339.9M 31.30%

Quarterly newest first

Period Free cash flow Change
Sep 2026 $152.4M (17.15%)
Jun 2026 $183.9M 76.06%
Mar 2026 $104.5M (35.44%)
Dec 2025 $161.8M 34.83%
43 more quarters

Against its own ten years

Low $9.9M High $1.3B
Ten-year median $339.9M
Current reading's percentile 64

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on RVTY